Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primo N Lara

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerJames R Rigas, Primo N Lara
CA: a Cancer Journal for Clinicians|January 13, 2026
Cancer statistics, 2026: Charting a course for a national cancer research agendaPrimo N Lara, Dawn L Hershman
Clinical Lung Cancer|February 18, 2014
Left behind? Drug discovery in extensive-stage small-cell lung cancerJonathan W Riess, Primo N Lara
Nature Reviews. Urology|July 23, 2014
Prostate cancer: Predicting response to androgen receptor signalling inhibitionChristopher P Evans, Primo N Lara
Clinical Lung Cancer|June 28, 2016
Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place?Megan E Daly, Primo N Lara
Nature Reviews. Clinical Oncology|November 25, 2010
Medical oncology: Chemoradiotherapy for NSCLC-does a 'standard' exist?Allen M Chen, Primo N Lara
Lung Cancer (Amsterdam, Netherlands)|March 25, 2006
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerJames R Rigas, Primo N Lara
Clinical Lung Cancer|July 16, 2008
Monoclonal antibodies versus tyrosine kinase inhibitors concurrent with chemotherapy in non-small-cell lung cancer: exploring divergent resultsPrimo N Lara, Suresh S Ramalingam
The Lancet. Oncology|November 12, 2013
Dasatinib and docetaxel in advanced prostate cancerPrimo N Lara, Christopher P Evans
JAMA Oncology|December 14, 2018
Cytoreductive Nephrectomy in Metastatic Renal Cell Cancer: Not All That It's Cut Out to BePrimo N Lara, Christopher P Evans
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|March 23, 2006
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerJames R Rigas, Primo N Lara
CA: a Cancer Journal for Clinicians|January 13, 2026
Cancer statistics, 2026: Charting a course for a national cancer research agendaPrimo N Lara, Dawn L Hershman
Clinical Lung Cancer|February 18, 2014
Left behind? Drug discovery in extensive-stage small-cell lung cancerJonathan W Riess, Primo N Lara
Nature Reviews. Urology|July 23, 2014
Prostate cancer: Predicting response to androgen receptor signalling inhibitionChristopher P Evans, Primo N Lara
Clinical Lung Cancer|June 28, 2016
Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place?Megan E Daly, Primo N Lara
Nature Reviews. Clinical Oncology|November 25, 2010
Medical oncology: Chemoradiotherapy for NSCLC-does a 'standard' exist?Allen M Chen, Primo N Lara
Lung Cancer (Amsterdam, Netherlands)|March 25, 2006
Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancerJames R Rigas, Primo N Lara
Clinical Lung Cancer|July 16, 2008
Monoclonal antibodies versus tyrosine kinase inhibitors concurrent with chemotherapy in non-small-cell lung cancer: exploring divergent resultsPrimo N Lara, Suresh S Ramalingam
The Lancet. Oncology|November 12, 2013
Dasatinib and docetaxel in advanced prostate cancerPrimo N Lara, Christopher P Evans
JAMA Oncology|December 14, 2018
Cytoreductive Nephrectomy in Metastatic Renal Cell Cancer: Not All That It's Cut Out to BePrimo N Lara, Christopher P Evans
Pageof 28